02-Nov-2026 13:17:49

Expansion

NARAYANA HEALTH Q2 FY27: REVENUE SURGES 73% YOY; TARGETS 7,834 BEDS BY FY30, ₹730 CR FY27 CAPEX PLANNED

• FY30 Bed Expansion Target: Management targets more than 7,800 beds by FY30, with planned additions of approximately 1,955 beds across upcoming projects • FY27 Capex Guidance: Planned expenditure of ₹730 Cr, including ₹460 Cr for greenfield/inorganic expansion and ₹270 Cr for replacement and maintenance • Capex Progress: FY27 actual expenditure disclosed at ₹163.6 Cr, including ₹95.5 Cr towards expansion and ₹68.1 Cr towards maintenance • Margin Performance: EBITDA margin stood at 21.3%, while PAT margin improved to 10.6% from 7.7% QoQ • HSR Bengaluru Expansion: New 215-bed greenfield hospital planned with ₹490 Cr investment, targeted for completion in FY28 • Rajarhat Kolkata Project: Developing a 350-bed greenfield hospital with ₹900 Cr investment, scheduled for completion in FY29 • Bengaluru Expansion: Plans 220-bed Central Bengaluru facility costing ₹160 Cr by FY29 and 350-bed South Bengaluru hospital costing ₹800 Cr by FY30 • Raipur Expansion: Adding 300 beds with approximately ₹540 Cr investment, targeted for completion in FY28 • Park Street Kolkata: New 120-bed leased facility planned with ₹100 Cr project cost, scheduled for FY28 • Additional Growth Pipeline: Another 400 beds included in the FY30 capacity roadmap, taking targeted capacity to 7,834 beds • India Business Growth: Revenue increased 16.6% YoY and 8.7% QoQ to ₹1,440.2 Cr, while EBITDA grew 30.8% YoY and 22.3% QoQ to ₹354.8 Cr • India Profitability: PAT surged 36.2% YoY and 44.2% QoQ to ₹189.9 Cr, supported by improving hospital operating performance • India Hospital Margins: Hospital EBITDA margin improved to 26.8% from 23.8% YoY and 24.8% QoQ • Cayman Islands Business: Revenue increased 28.2% YoY and 8.9% QoQ to $63.4 Mn, while EBITDA grew 23.8% YoY and 46.4% QoQ to $22.1 Mn • UK Business: Revenue declined 0.9% QoQ to £64.4 Mn, while EBITDA fell 18.5% QoQ to £4.7 Mn; PAT recorded a loss of £2.7 Mn • UK Margin Pressure: Post-IFRS EBITDA margin declined to 7.2% from 8.8% QoQ, including £0.8 Mn losses from new centres • Insurance Business: India insurance PAT loss widened to ₹15.1 Cr from ₹4.2 Cr YoY, with combined operating ratio increasing to 282% • Hospital Network: Operates 56 healthcare facilities with 6,119 operational beds across India, the UK and Cayman Islands • New Hospital Launch: Banashankari Hospital in Bengaluru commenced operations in late September 2026, with operating performance expected to be reflected from Q3 FY27 • Digital Hospital Expansion: Introducing paperless patient journeys through NHCare, WhatsApp-enabled admissions, digital consultations, billing, payments and discharge processes • Balance Sheet: Consolidated net debt stood at ₹1,883 Cr, with net debt-to-equity ratio at 0.38x as of September 2026 • Future Growth Strategy: Focused on hospital capacity expansion, strengthening Bengaluru and Kolkata presence, improving utilisation, scaling international operations and digitalising patient services

← Back to feed